Capitation in nephrology: the time has come.
Nephrology represents a powerful example of the impact of new medical technology; almost 200,000 patients are alive in the United States because of renal replacement therapy. However, ESRD patient morbidity and life expectancy are still serious concerns despite advances in medical treatment. A capitated payment system for end-stage renal disease (ESRD) could be a great benefit to the renal community as it would force us to rethink the way ESRD care is provided. By applying the concepts of integration of services, disease management, and case management to ESRD care under a capitated payment system, providers may be able to improve patient outcomes and overall well-being.
Bosch
J P
JP
Renal Hypertension Division, George Washington University Medical Center, Washington, DC 20037, USA.
Luckenbill
L
L
D002204:Capitation Fee; D006801:Humans; D007676:Kidney Failure, Chronic / Q000191:economics*; D006278:Medicare / Q000191:economics*; D017582:Renal Replacement Therapy / Q000191:economics*; D014481:United States